Werewolf Therapeutics Inc.

12/01/2021 | Press release | Distributed by Public on 12/01/2021 07:06

Werewolf Therapeutics to Present Preclinical Data on INDUKINE™ Molecules at the 63rd American Society of Hematology (ASH) Annual Meeting